Abstract
Myc is an important regulator of many cellular processes, including growth promotion, differentiation, and apoptosis. The mechanisms underlying Myc biological activity, however, remain elusive. For many years, research in the field has focused on the idea of Myc as a transactivator of gene expression. More recently, alternative mechanisms of Myc function have been proposed, including gene repression. In this review we present several lines of evidence to support a connection between Myc-mediated transformation and transcriptional repression.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Adams JM, Harris AW, Pinkert CA, Corcoran LM, Alexander WS, Cory S, Palmiter RD and Brinster RL. . 1985 Nature 318: 533–538.
Amati B, Brooks MW, Levy N, Littlewood T, Evan G and Land H. . 1993a Cell 72: 233–245.
Amati B, Littlewood TD, Evan GI and Land H. . 1993b EMBO J. 12: 5083–5087.
Amundson SA, Zhan Q, Penn LZ and Fornace AJ. . 1998 Oncogene 17: 2149–2154.
Auvinene M, Paasinen A, Andersson LC and Hollta E. . 1992 Nature 360: 355–358.
Barr LF, Campbell SE, Penno MB, Ball DW and Baylin SB. . 1996 Cell Growth Diff. 7: 1149–1156.
Barr LF, Campbell SE, Bochner BS and Dang CV. . 1998 Cancer Res. 58: 5537–5545.
Blackwell TK, Kretzner L, Blackwood EM, Eisenman RN and Weintraub H. . 1990 Science 250: 1149–1151.
Blackwell TK, Huang J, Ma A, Kretzner L, Alt FW, Eisenman RN and Weintraub H. . 1993 Mol. Cell. Biol. 13: 5216–5224.
Blackwood E and Eisenman RN. . 1991 Science 251: 1211–1217.
Blanchard JM, Piechaczyk M, Dani C, Chambard JC, Franchi A, Pouyssegur J and Jeanteur P. . 1985 Nature 317: 443–445.
Brockmann D and Esche H. . 1995 Curr. Topics Micro. Immunol. 199: 81–112.
Brough DE, Hofmann TJ, Ellwood KB, Townley RA and Cole MD. . 1995 Mol. Cell. Biol. 15: 1536–1544.
Bush A, Mateyak M, Dugan K, Obaya A, Adachi S, Sedivy J and Cole M. . 1998 Genes Dev. 12: 3797–3802.
Chen C, Nussenzweig A, Guo M, Kim D, Li GC and Ling CC. . 1996 Oncogene 13: 1659–1665.
Cleveland JL, Huleihel M, Bressler P, Siebenlist U, Akiyama L, Eisenman RN and Rapp UR. . 1988 Oncogene Res. 3: 357–375.
Corden J, Wasylyk B, Buchwadler A, Sassone-Corsi P, Kedinger C and Chambon P. . 1980 Science 209: 1406–1414.
Counter CM, Avilion AA, LeFeuvre CE, Stewart NG, Greider CW, Harley CB and Bacchetti S. . 1992 EMBO J. 11: 1921–1929.
Crouch DH, Gallagher R, Goding CR, Neil JC and Fulton R. . 1996 Nucleic Acids Res. 24: 3216–3221.
DePinho RA, Schreiber-Agus N and Alt FW. . 1991 Adv. Cancer Res. 57: 1–47.
Desbarats L, Gaubatz S and Eilers M. . 1996 Genes Dev. 10: 447–460.
Facchini LM, Chen S, Marhin WW, Lear JN and Penn LZ. . 1997 Mol. Cell. Biol. 17: 100–114.
Facchini LM and Penn LZ. . 1998 FASEB J. 12: 633–651.
Figge J, Webster T, Smith TF and Paucha E. . 1988 J. Virol. 62: 1814–1818.
Gaubatz S, Meichle A and Eilers M. . 1994 Mol. Cell Biol. 14: 3853–3862.
Grandori C and Eisenman RN. . 1997 Trends Biochem. Sci. 22: 177–181.
Greenberg R, O'Hagan R, Deng H, Xiao Q, Hann S, Adams R, Lichtsteiner S, Chin L, Morin G and DePinho R. . 1999 Oncogene 18: 1219–1238.
Griffioen M, Steegenga WT, Ouwerkerk IJM, Peltenburg LTC, Jochemsen AG and Schrier PI. . 1998 Mol. Immunol. 35: 829–835.
Grignani F, Lombardi L, Inghirami G, Sternas L, Cechova K and Dalla-Favera R. . 1990 EMBO J 9: 3913–3922.
Hann SR, Dixit M, Sears RC and Sealy L. . 1994 Genes Dev. 8: 2441–2452.
Hateboer GH, Timmers H, Rustgi A, Billaud M, van't Veer L and Bernards R. . 1993 Proc. Natl. Acad. Sci. USA 90: 8489–8493.
Heaney ML, Pierce J and Parsons JT. . 1986 J.Virol. 60: 167–176.
Henriksson M, Bakardjiev A, Klein G and Luscher B. . 1993 Oncogene 8: 3199–3209.
Henriksson M and Luscher B. . 1996 Adv. Cancer Res. 68: 109–182.
Hoang A, Lutterbach B, Lewis BC, Yano T, Chou T-Y, Barrett J, Raffeld M, Hann SR and Dang CV. . 1995 Mol. Cell. Biol. 15: 4031–4042.
Inghirami G, Grignani F, Sternas L, Lombardi L, Knowles DM and Dalla-Favera R. . 1990 Science 250: 682–686.
Jones N. . 1995 Curr. Topics Micro. Immunol. 199: 59–80.
Karn J, Watson JV, Lowe AD, Green SM and Vedckis W. . 1989 Oncogene 4: 773–787.
Kastan MB, Zhan Q, El-Deiry WS, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B and Fornace AJ. . 1992 Cell 71: 587–597.
Keath EJ, Caimi PG and Cole MD. . 1984 Cell 39: 339–348.
Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PLC, Coviello GM, Wright WE, Weinrich SL and Shay JW. . 1994 Science 266: 2011–2015.
Kretzner L, Blackwood EM and Eisenman RN. . 1992 Nature 359: 426–429.
Land H, Parada LF and Weinberg RA. . 1983 Nature 304: 596–602.
Lee LA, Dolde C, Barrett J, Wu CS and Dang CV. . 1996 J. Clin. Invest. 97: 1687–1695.
Lee LA and Dang CV. . 1997 Curr. Topics Micro. Immunol. 224: 131–135.
Lee TC, Li L, Philipson L and Ziff EB. . 1997 Proc. Natl. Acad. Sci. USA 94: 12886–12891.
Lemaitre J-M, Buckle RS and Mechali M. . 1996 Adv. Cancer Res. 70: 95–144.
Li L, Prendergast G, MacGregor D and Ziff EB. . 1994 EMBO J. 13: 4070–4079.
Littlewood TD, Hancock DC, Danielian PS, Parker MG and Evan GI. . 1995 Nucleic Acids Research 23: 1686–1690.
Lombardi L, Newcomb EW and Dalla-Favera R. . 1987 Cell 49: 161–170.
Lutterbach B and Hann SR. . 1994 Mol. Cell Biol. 14: 5510–5522.
Lutterbach B and Hann SR. . 1997 Oncogene 14: 967–975.
Mai S and Martensson IL. . 1995 Nucl. Acids Res. 23: 1–9.
Marcu KB, Bossone SA and Patel AJ. . 1992 Ann. Rev. Biochem. 61: 809–860.
Marhin WW, Chen S, Facchini LM, Fornace AJ and Penn LZ. . 1997 Oncogene 14: 2825–2834.
Mateyak MK, Obaya AJ, Adachi S and Sedivy JM. . 1997 Cell Growth Diff. 8: 1039–1048.
McMahon SB, Van Buskirk HA, Dugan KA, Copeland TD and Cole MD. . 1998 Cell 94: 363–374.
Mink S, Mutschler B, Weiskirchen R, Bister K and Klempnauer KH. . 1996 Proc. Natl. Acad. Sci. USA 93: 6635–6640.
Morgan DO. . 1995 Nature 374: 131–134.
Moshier JA, Dosecu J, Skunca M and Luk GD. . 1993 Cancer Research 53: 2618–2622.
Nevins JR. . 1995 Curr. Topics Micro. Immunol. 199: 25–32.
Paganin C, Bianchi G, Lombardi L, Dalla Favera R, Mantovani A and Allavena P. . 1994 Int. J. Clin. Lab. Res. 24: 29–32.
Penn LZ, Brooks MW, Laufer EM and Land H. . 1990 EMBO J. 9: 1113–1121.
Perez-Roger I, Solomon DLC, Sewing A and Land H. . 1997 Oncogene 14: 2373–2381.
Peukert K, Staller P, Schneider A, Carmichael G, Hanel F and Eilers M. . 1997 EMBO J. 16: 5672–5686.
Pulverer BJ, Fischer K, Vousden K, Littlewood T, Evan G and Woodgett JR. . 1994 Oncogene 9: 59–70.
Ralston R and Bishop JM. . 1983 Nature 306: 803–806.
Ralston R. . 1991 Nature 353: 866–868.
Roy AL, Meisterernst M, Pognonec P and Roeder RG. . 1991 Nature 345: 245–248.
Roy AL, Malik S, Meisterernst M and Roeder R. . 1993a Nature 365: 355–358.
Roy AL, Carruthers C, Gutjahr T and Roeder RG. . 1993b Nature 365: 359–361.
Ruley HE. . 1990 Cancer Cells 2: 258–268.
Sakamuro D, Elliott KJ, Wechsler-Reya R and Prendergast GC. . 1996 Nature Gen. 14: 69–77.
Sanchez Y and Elledge SJ. . 1995 BioEssays 17: 545–548.
Sarid J, Halazonetis TD, Murphy W and Leder P. . 1987 Proc. Natl. Acad. Sci. USA 84: 170–173.
Schneider C, King RM and Philipson L. . 1988 Cell 54: 787–793.
Schneider A, Peukert K, Eilers M and Hanel F. . 1997 Curr. Topics Micro. Immunol. 224: 137–146.
Schreiber-Agus N and DePinho RA. . 1998 BioEssays 20: 808–818.
Serrano M, Lin AW, McCurrach ME, Beach D and Lowe SW. . 1997 Cell. 88: 593–602.
Shenk T and Flint J. . 1991 Adv. Cancer Res. 57: 47–85.
Sherr CJ. . 1994 Cell 79: 551–555.
Sherr CJ and Roberts JM. . 1995 Genes Dev. 9: 1149–1163.
Smale ST and Baltimore D. . 1989 Cell 57: 103–113.
Small MB, Hay N, Schwab M and Bishop J. . 1987 Mol. Cell. Biol. 7: 1638–1645.
Smith ML, Chen IT, Zhan Q, Bae I, Chen CY, Gilmer TM, Kastan MB, O'Connor PM and Fornace AJ. . 1994 Science 266: 1376–1380.
Solomon DLC, Amati B and Land H. . 1993 Nuc. Acids Res. 21: 5372–5376.
Soucek L, Helmer-Citterich M, Sacco A, Jucker R, Cesareni G and Nasi S. . 1998 Oncogene 17: 2463–2472.
Spencer CA and Groudine M. . 1991 Adv. Cancer Res. 56: 1–48.
Spotts GD, Patel SV, Xiao Q and Hann SR. . 1997 Mol. Cell. Biol. 17: 1459–1468.
Springer TA, Dustin ML, Kishimoto TK and Marlin SD. . 1987 Ann. Rev. Immunol. 5: 223–252.
Steiner P, Philipp A, Lukas J, Godden-Kent D, Pagano M, Mittnacht S, Bartek J and Eilers M. . 1995 EMBO J. 14: 4814–4826.
Stone J, de Lange T, Ramsay G, Jakobovits E, Bishop JM, Varmus H and Lee W. . 1987 Mol. Cell. Biol. 7: 1697–1709.
Suen T-C and Hung M-C. . 1991 Mol. Cell. Biol. 11: 354–362.
Taparowsky EJ, Heaney ML and Parsons JT. . 1987 Cancer Res. 47: 4125–4129.
Tikhoneneko AT, Black DJ and Linial ML. . 1996 J. Biol. Chem. 271: 30741–30747.
Vlach J, Hennecke S, Alevizopoulos K, Conti D and Amati B. . 1996 EMBO J. 15: 6595–6604.
Wang J, Xie LY, Allan S, Beach D and Hannon GJ. . 1998 Genes Dev. 12: 1769–1774.
White E. . 1995 Curr. Topics Micro. Immunol. 199: 34–58.
Xiao Q, Claassen G, Shi J, Adachi S, Sedivy J and Hann SR. . 1998 Genes Dev. 12: 3803–3808.
Zakian VA. . 1997 Cell 91: 1–3.
Zantema A and van der Eb AJ. . 1995 Curr. Topics Micro. Immunol. 199: 1–23.
Zhan Q, Bae I, Kastan MB and Fornace AJ. . 1994a Cancer Res. 54: 2755–2760.
Zhan Q, Lord KA, Alamo I, Hollander MC, Carrier F, Ron D, Kohn KW, Hoffman B, Liebermann DA and Fornace AJ. . 1994b Mol. Cell. Biol. 14: 2361–2371.
Acknowledgements
We would like to thank Linda Penn, Sara Oster, Rebecca Chinery, Qiurong Xiao, Juliet Daniel, and Mark Gregory for critical reading. We would also like to thank Linda Penn and Gail Sonenshein for sharing their data for the purpose of this review.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Claassen, G., Hann, S. Myc-mediated transformation: the repression connection. Oncogene 18, 2925–2933 (1999). https://doi.org/10.1038/sj.onc.1202747
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1202747
Keywords
This article is cited by
-
Transactivation Domain of Human c-Myc Is Essential to Alleviate Poly(Q)-Mediated Neurotoxicity in Drosophila Disease Models
Journal of Molecular Neuroscience (2017)
-
Identification of molecular sub-networks associated with cell survival in a chronically SIVmac-infected human CD4+ T cell line
Virology Journal (2014)
-
Reversal by RARα agonist Am580 of c-Myc-induced imbalance in RARα/RARγ expression during MMTV-Myc tumorigenesis
Breast Cancer Research (2012)
-
Identification of c-myc-dependent proteins in the medulloblastoma cell line D425Med
Amino Acids (2012)
-
Gefitinib induces apoptosis and decreases telomerase activity in MDA-MB-231 human breast cancer cells
Archives of Pharmacal Research (2009)